Skip to main content

What the FDA labels say about taking them together

Ephedrine and tolcapone

Tolcapone's FDA label of October 2, 2020 names ephedrine in its drug interactions section; the ephedrine labels PlainMeds reads (4) do not name tolcapone. The tolcapone label: “Drugs That Increase Catecholamines: Tolcapone did not influence the effect of ephedrine, an indirect sympathomimetic, on hemodynamic parameters or plasma catecholamine levels, either at rest or during exercise.”

Check it at the source: the ephedrine FDA label on DailyMed (effective September 16, 2024, Nexus Pharmaceuticals, LLC); the tolcapone FDA label on DailyMed (effective October 2, 2020, Bausch Health US LLC).

What does the ephedrine label say about tolcapone?

Ephedrine's label (effective September 16, 2024) and its 3 other brand-application labels do not name tolcapone in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Emerphed PFS), Nexus Pharmaceuticals, LLC, effective September 16, 2024 (SPL set 14601778-93ac-43ec-b66b-5a942317133f), via openFDA; the full label on DailyMed

What does the tolcapone label say about ephedrine?

Tolcapone label, drug interactions

Drugs That Increase Catecholamines: Tolcapone did not influence the effect of ephedrine, an indirect sympathomimetic, on hemodynamic parameters or plasma catecholamine levels, either at rest or during exercise.

Source: FDA drug label (Tasmar), Bausch Health US LLC, effective October 2, 2020 (SPL set a0e47a9d-78e7-4523-983a-aa259f221736), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

19Ephedrine generic labelers
1Tolcapone generic labelers
EphedrineTolcapone
Labeled forAsthmaParkinson's disease
Boxed warningNoYes
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?